Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Onyx Pharmaceuticals
Information provided by (Responsible Party):
Luciano Jose Costa, MD, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT01690143
First received: July 17, 2012
Last updated: August 31, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2018
  Estimated Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)